Back to
FIRST MANHATTAN CO. LLC.
CORT
Showing 0 of 8 quarters
Position history for
FIRST MANHATTAN CO. LLC.'s holdings in CORCEPT THERAPEUTICS INC
No. First Manhattan exited its CORT (Corcept Therapeutics) position in Q4 2021. Its Q3 2021 13F listed 1,000 shares worth $19,000. First Manhattan first reported CORT in Q1 2020 and held it in 7 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.